As COVID-19 continues to run its course, the likeliest long-term outcome is that the virus SARS-CoV-2 becomes endemic in large swaths of the world, constantly circulating among the human population but causing fewer cases of severe disease. Eventually—years or even decades in the future—COVID-19 could transition into a mild childhood illness, like the four endemic human coronaviruses that contribute to the common cold.
The initial batch of COVID-19 vaccines are now available in the U.S. following incredibly fast — “warp speed” — development and testing.
Not so incredibly, there’s a lot of confusion among cancer patients — as well as their oncologists and caregivers — as to whether the vaccine is a good idea or a bad idea for somebody dealing with cancer.
A new study shows immune cells primed to fight the coronavirus should persist for a long time after someone is vaccinated or recovers from infection.
Early in the pandemic, people with COVID-19 began reporting an odd symptom: the loss of smell and taste.
The reason wasn't congestion. Somehow, the SARS-CoV-2 virus appeared to be affecting nerves that carry information from the nose to the brain.
That worried neurologists.
The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators identified no safety concerns and no evidence of vaccine-associated enhanced respiratory disease (VAERD).
LONDON — Several European countries have banned flights from the U.K. over fears about a new coronavirus variant that has forced millions of people in Britain to cancel their Christmas plans.
The US Food and Drug Administration on Friday night authorized a second coronavirus vaccine for emergency use as Covid-19 hospitalizations, cases and deaths are piling up in unprecedented ways.
The FDA had signaled it would issue the authorization quickly for Moderna's vaccine candidate, after the agency's vaccine advisers voted Thursday to recommend approval.
LONDON, Nov 9 (Reuters) - Many COVID-19 survivors are likely to be at greater risk of developing mental illness, psychiatrists said on Monday, after a large study found 20% of those infected with the coronavirus are diagnosed with a psychiatric disorder within 90 days.
Anxiety, depression and insomnia were most common among recovered COVID-19 patients in the study who developed mental health problems, and the researchers also found significantly higher risks of dementia, a brain impairment condition.
(CNN)President-elect Joe Biden and Vice President-elect Kamala Harris' newly appointed Transition Covid-19 Advisory Board is led by established public health officials and staffed by a mix of doctors and current and former government officials, some with high-profile media visibility.
(CNN)Scientists Ugur Sahin and Ozlem Tureci have dedicated their lives to the field of oncology and infectious diseases, and spent years pioneering personalized immunotherapy treatments for cancer.
